Proopiomelanocortin: Physiology and What Research Reports

Proopiomelanocortin (POMC) is a prohormone — a single long polypeptide that enzymes inside secretory cells cleave into several smaller, biologically active peptides. Those products include adrenocorticotropic hormone (ACTH), the melanocyte-stimulating hormones (α-, β- and γ-MSH), β-lipotropin and the opioid peptide β-endorphin. Because one gene yields many signalling molecules, POMC is one of the most frequently cited examples of post-translational processing in endocrinology. A 2019 review of POMC evolution described the gene as ancient and broadly conserved across vertebrates, with tissue-specific processing enzymes generating different peptide repertoires in different cell types (PMID 31421696).

This page is for educational purposes only and is not medical advice; consult a licensed physician about any medical question, symptom or treatment decision.

Where POMC Is Produced

POMC expression is not confined to one organ. The classic sites are the anterior pituitary corticotrophs, which release ACTH into the circulation, and the intermediate-lobe melanotrophs of many species. A second major site is the hypothalamic arcuate nucleus: a 2013 review of central POMC neural circuits described arcuate POMC neurons and their projections as a core component of the melanocortin system involved in energy homeostasis (PMID 23440036).

POMC is also expressed peripherally. A 2023 review in the psychodermatology literature described a cutaneous POMC system in keratinocytes, melanocytes and immune cells, and discussed POMC-derived peptides as candidate mediators linking stress signalling with skin biology (PMID 37275429).

POMC-Derived Peptides at a Glance

What Studies Report About POMC Function

Feeding and appetite

Much of the experimental work uses rodents. Researchers reported that growth hormone/STAT5 signalling within POMC neurons regulated glucoprivic hyperphagia in mice, linking a hormonal input to POMC-neuron control of feeding (PMID 31494175). A separate mouse study reported that deficiency of CAPS2, a protein involved in dense-core vesicle secretion, caused POMC accumulation in the pituitary and altered food intake behaviour (PMID 32891671). Synaptic inputs to these cells also appear context-dependent: the study of endocannabinoid signalling at hypothalamic steroidogenic factor-1/POMC synapses reported that this signalling was sensitive to both sex and diet in mice (PMID 29973869).

Glucose homeostasis

POMC neurons are studied not only for body weight but for metabolic control more broadly. A 2018 mouse study reported that hypothalamic POMC was necessary for normal glucose homeostasis in female mice, indicating sex-specific consequences of losing hypothalamic POMC expression (PMID 30283405).

Gene regulation in pituitary cells

Another research strand asks how POMC transcription itself is switched on and off. Researchers described the structural basis of the transcription factor NR4A1 bound to the human pituitary POMC gene promoter, providing a molecular picture of one regulatory interaction (PMID 31822342). Work in AtT-20 corticotroph cells reported that the co-chaperones Fkbp4 and Fkbp5 had differing effects on POMC gene regulation (PMID 34072036).

Light, skin and sensory signalling

POMC also appears in studies connecting skin exposure to central signalling. An experimental dermatology study reported that ultraviolet B stimulated POMC signalling in the arcuate nucleus of the hypothalamus in mice (PMID 26513428). In humans, a 2016 report described a biomimetic POMC peptide applied topically and reported suppression of capsaicin-induced sensory irritation in human volunteers (PMID 28003842).

POMC Deficiency and Melanocortin Pharmacology: What Studies Report

The clearest clinical illustration of POMC's role comes from rare genetic deficiency. A 2016 New England Journal of Medicine report described patients with POMC deficiency treated with the melanocortin-4 receptor agonist setmelanotide, and the authors reported weight loss and reduced hunger with treatment (PMID 27468060). That report is frequently cited as evidence that the downstream melanocortin receptor can be engaged even when the precursor peptide is absent. The verified literature summarised here does not characterise a full safety or tolerability profile for melanocortin agonists, and no dosing information beyond what the cited report describes is discussed on this page.

How POMC Is Measured and Studied

Methods differ depending on whether the question is about the protein, the gene or the neurons:

• Immunoassays and peptide analysis for POMC and its cleavage products, such as ACTH, in blood or tissue extracts.
• Tissue expression mapping in brain and skin; reviews of central POMC circuits describe arcuate expression and projection anatomy (PMID 23440036).
• Genetic mouse models in which POMC is deleted or altered in specific cells; one such model reported impaired glucose homeostasis in female mice (PMID 30283405).
• Cell lines such as murine AtT-20 corticotrophs, used to dissect POMC gene regulation (PMID 34072036).
• Structural biology of transcription factors bound to the POMC promoter (PMID 31822342).
• Comparative and evolutionary analysis across vertebrate species (PMID 31421696).

Why Readers Meet This Term

POMC appears constantly in peptide literature because so many named peptides are its fragments or act on the receptors those fragments target. Discussions of melanocortin receptors, of ACTH and the stress axis, of pigmentation biology, and of appetite-related melanocortin pharmacology all trace back to this one precursor. Understanding that POMC is a precursor — not a single hormone with a single action — helps explain why effects attributed to "POMC peptides" differ so much between tissues, as the evolutionary review emphasised when describing tissue-specific processing (PMID 31421696).

Limitations of the Evidence

Most mechanistic findings above come from mice or from cultured pituitary cells, and researchers reported sex- and diet-dependent differences in several of them (PMID 29973869), so results do not transfer automatically to humans. Human data in this collection are narrow: a rare-disease treatment report (PMID 27468060) and a small sensory-irritation study of a topical biomimetic peptide (PMID 28003842). Nothing here establishes outcomes in healthy people, and none of it constitutes guidance for any individual.

References

• Evolution of proopiomelanocortin (Vitamins and Hormones, 2019)
• Proopiomelanocortin (POMC) and psychodermatology (Skin Health and Disease, 2023)
• Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist (The New England Journal of Medicine, 2016)
• Unraveling the central proopiomelanocortin neural circuits (Frontiers in Neuroscience, 2013)
• Hypothalamic Proopiomelanocortin Is Necessary for Normal Glucose Homeostasis in Female Mice (Frontiers in Endocrinology, 2018)
• Growth hormone/STAT5 signaling in proopiomelanocortin neurons regulates glucoprivic hyperphagia (Molecular and Cellular Endocrinology, 2019)
• Endocannabinoid Signaling at Hypothalamic Steroidogenic Factor-1/Proopiomelanocortin Synapses Is Sex- and Diet-Sensitive (Frontiers in Molecular Neuroscience, 2018)
• Biomimetic proopiomelanocortin suppresses capsaicin-induced sensory irritation in humans (Research in Pharmaceutical Sciences, 2016)
• Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells (International Journal of Molecular Sciences, 2021)
• CAPS2 deficiency induces proopiomelanocortin accumulation in pituitary and affects food intake behavior in mice (Neuroscience Letters, 2020)
• Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter (Biochemical and Biophysical Research Communications, 2020)
• Ultraviolet B stimulates proopiomelanocortin signalling in the arcuate nucleus of the hypothalamus in mice (Experimental Dermatology, 2016)